1
|
Munisamy M, Rathinam B, Shanmugasundaram E, Ganesan V, Narayanan V, Balakrishnan SB, Kaliyamoorthy S, Thambusamy S. β-Cyclodextrin-Encapsulated Rhodamine Derivatives Core-Shell Microspheres-Based Fluorescent Sensor for Au 3+ and Template for Generating Microplates of Gold. Micromachines (Basel) 2023; 14:1443. [PMID: 37512754 PMCID: PMC10384120 DOI: 10.3390/mi14071443] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/07/2023] [Revised: 07/12/2023] [Accepted: 07/14/2023] [Indexed: 07/30/2023]
Abstract
We have developed β-cyclodextrin-encapsulated rhodamine derivative core-shell microspheres (β-CD@RH) to improve their aqueous solubility and biocompatibility. The β-CD@RH core-shell microspheres exhibited bright and stable fluorescence with Au3+ ion in aqueous media. The development of triangular and hexagonal gold microplates within an aqueous solution by a simple, one-step, and green chemistry strategy is followed and prepared. Fluorescent imaging of Au3+ in living cells is also successfully demonstrated.
Collapse
Affiliation(s)
- Maniyazagan Munisamy
- Department of Industrial Chemistry, School of Chemical Sciences, Alagappa University, Karaikudi 630003, India
- Department of Nanotechnology and Advanced Materials Engineering, Sejong University, Seoul 05006, Republic of Korea
| | - Balamurugan Rathinam
- Department of Chemical and Materials Engineering, National Yunlin University of Science and Technology, Yunlin 64002, Taiwan
| | | | - Vigneshkumar Ganesan
- Department of Industrial Chemistry, School of Chemical Sciences, Alagappa University, Karaikudi 630003, India
| | - Vimalasruthi Narayanan
- Department of Industrial Chemistry, School of Chemical Sciences, Alagappa University, Karaikudi 630003, India
| | | | - Selvam Kaliyamoorthy
- Department of Chemistry for Materials, Graduate School of Engineering, Mie University, Tsu 514-8507, Japan
| | - Stalin Thambusamy
- Department of Industrial Chemistry, School of Chemical Sciences, Alagappa University, Karaikudi 630003, India
| |
Collapse
|
2
|
Zhao C, Xie Z, Ma C, Deng X, Hong C, Sun S. Highly Stable Hybrid Ligand Double-Enhanced Electrochemiluminescence for Sensitive Detection of Cu2+. Microchem J 2022. [DOI: 10.1016/j.microc.2022.108237] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
3
|
Wu M, Zhang Z, Yong J, Schenk PM, Tian D, Xu ZP, Zhang R. Determination and Imaging of Small Biomolecules and Ions Using Ruthenium(II) Complex-Based Chemosensors. Top Curr Chem (Cham) 2022; 380:29. [PMID: 35695976 PMCID: PMC9192387 DOI: 10.1007/s41061-022-00392-8] [Citation(s) in RCA: 10] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2021] [Accepted: 05/27/2022] [Indexed: 01/13/2023]
Abstract
Luminescence chemosensors are one of the most useful tools for the determination and imaging of small biomolecules and ions in situ in real time. Based on the unique photo-physical/-chemical properties of ruthenium(II) (Ru(II)) complexes, the development of Ru(II) complex-based chemosensors has attracted increasing attention in recent years, and thus many Ru(II) complexes have been designed and synthesized for the detection of ions and small biomolecules in biological and environmental samples. In this work, we summarize the research advances in the development of Ru(II) complex-based chemosensors for the determination of ions and small biomolecules, including anions, metal ions, reactive biomolecules and amino acids, with a particular focus on binding/reaction-based chemosensors for the investigation of intracellular analytes’ evolution through luminescence analysis and imaging. The advances, challenges and future research directions in the development of Ru(II) complex-based chemosensors are also discussed.
Collapse
Affiliation(s)
- Miaomiao Wu
- Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, QLD, 4072, Australia
| | - Zexi Zhang
- Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, QLD, 4072, Australia
| | - Jiaxi Yong
- Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, QLD, 4072, Australia
| | - Peer M Schenk
- School of Agriculture and Food Sciences, The University of Queensland, Brisbane, QLD, 4072, Australia
| | - Dihua Tian
- Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, QLD, 4072, Australia
| | - Zhi Ping Xu
- Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, QLD, 4072, Australia
| | - Run Zhang
- Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, QLD, 4072, Australia.
| |
Collapse
|
4
|
Davoodi A, Eslami S, Fakhar M, Aazadbakht M, Montazeri M, Khoshvishkaie E, Keighobadi M. Aurothiomalate-Based Drugs as Potentially Novel Agents Against Leishmania major: A Mini Review. Acta Parasitol 2022; 67:640-647. [PMID: 35380401 DOI: 10.1007/s11686-022-00536-2] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/11/2021] [Accepted: 03/10/2022] [Indexed: 12/01/2022]
Abstract
PURPOSE Leishmaniasis is a major public health problem worldwide in many parts of the world. Current anti-leishmanial drugs have only limited clinical efficacy. Aurothiomalate derivatives are useful for treating rheumatoid arthritis, but have emerged as a promising therapeutic candidate for leishmaniasis. This paper gives a review of the literature about the usefulness of aurothiomalate derivatives against leishmaniasis. METHODS In this study, we reviewed the proposed mechanisms of action of aurothiomalate and related compounds on the metabolism of L. major and collected data by searching relevant articles. RESULTS Aurothiomalate-based drugs could be effective against leishmaniasis through two direct and indirect mechanisms: first, cytotoxic effects on parasites via thiomalate's false substrate role in the citric acid cycle against malate; and second, immunosuppressive and anti-inflammatory effects of aurothiomalate derivatives with prostaglandin production inhibitory effects. CONCLUSIONS The current study documented that aurothiomalate-based drugs could be effective against leishmaniasis through two direct and indirect mechanisms of action. Gold thiomalate as a promising hit should be evaluated against L. major in vitro and in vivo conditions in the future.
Collapse
Affiliation(s)
- Ali Davoodi
- Department of Pharmacognosy, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran
| | - Shahram Eslami
- Toxoplasmosis Research Center, Communicable Diseases Institute, Iranian National Registry Center for Lophomoniasis and Toxoplasmosis, School of Medicine, Mazandaran University of Medical Sciences, Farah Abad, 48471-91971, Sari, Iran
| | - Mahdi Fakhar
- Toxoplasmosis Research Center, Communicable Diseases Institute, Iranian National Registry Center for Lophomoniasis and Toxoplasmosis, School of Medicine, Mazandaran University of Medical Sciences, Farah Abad, 48471-91971, Sari, Iran.
- Toxoplasmosis Research Center, Communicable Diseases Institute, Iranian National Registry Center for Hydatid Cyst, Mazandaran Branch, Mazandaran University of Medical Sciences, Sari, Iran.
| | - Mohammad Aazadbakht
- Department of Pharmacognosy, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran
| | - Mahbobeh Montazeri
- Toxoplasmosis Research Center, Communicable Diseases Institute, Iranian National Registry Center for Lophomoniasis and Toxoplasmosis, School of Medicine, Mazandaran University of Medical Sciences, Farah Abad, 48471-91971, Sari, Iran
- Toxoplasmosis Research Center, Communicable Diseases Institute, Iranian National Registry Center for Hydatid Cyst, Mazandaran Branch, Mazandaran University of Medical Sciences, Sari, Iran
| | - Elnaz Khoshvishkaie
- Pharmaceutical Cares Department, Ayatollah Khamenei Hospital, Mazandaran University of Medical Sciences, Abbas Abad, Iran
| | - Masoud Keighobadi
- Toxoplasmosis Research Center, Communicable Diseases Institute, Iranian National Registry Center for Lophomoniasis and Toxoplasmosis, School of Medicine, Mazandaran University of Medical Sciences, Farah Abad, 48471-91971, Sari, Iran.
- Toxoplasmosis Research Center, Communicable Diseases Institute, Iranian National Registry Center for Hydatid Cyst, Mazandaran Branch, Mazandaran University of Medical Sciences, Sari, Iran.
| |
Collapse
|